{
    "clinical_study": {
        "@rank": "84036", 
        "acronym": "TAP Block", 
        "arm_group": [
            {
                "arm_group_label": "Bupivacaine 0.5%", 
                "arm_group_type": "Experimental", 
                "description": "Drug"
            }, 
            {
                "arm_group_label": "Bupivacaine 0.25%", 
                "arm_group_type": "Experimental", 
                "description": "Drug"
            }, 
            {
                "arm_group_label": "Normal Saline", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "Adding TAP block with Bupivacaine may decrease the use of PCA bolus use after caesarean\n      section for pain relief."
        }, 
        "brief_title": "Transversus Abdominis Plane (TAP) Block for Post Caesarian Pain", 
        "condition": "Pain Score and Number of PCA Bolus Used by Patients", 
        "detailed_description": {
            "textblock": "Participants in the study will be randomized to TAP block with 0.5% or 0.25% bupivacaine or\n      with placebo (normal saline).\n\n      The number of PCA bolus used within 24 hours post cesarean section will be compared between\n      the groups."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Healthy pregnant (ASA II) patients presenting for planned Cesarean delivery at New York\n        Methodist Hospital under combined spinal epidural anesthesia\n\n        Exclusion Criteria:\n\n          -  They are unable or are unwilling to take part in the study\n\n          -  They have a history of allergy to any of the medications to be used in the study\n\n          -  They have a history of drug abuse or chronic pain or opioid use\n\n          -  They weigh less than 60kg\n\n          -  They have a multiple gestation, placental disease, preeclampsia other disease of\n             pregnancy\n\n          -  They have a contraindication to neuraxial anesthesia (i.e., bleeding problems,\n             bacteremia, etc.)\n\n          -  They are unable to understand instructions or questions related to the study\n\n          -  ASA III or IV"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 7, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01986049", 
            "org_study_id": "IRBNet # 367320"
        }, 
        "intervention": {
            "arm_group_label": [
                "Bupivacaine 0.5%", 
                "Bupivacaine 0.25%"
            ], 
            "intervention_name": "Bupivacaine", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Bupivacaine"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "November 14, 2013", 
        "location": {
            "contact": {
                "email": "adg9003@nyp.org", 
                "last_name": "Adel Guirguis, MD, MS", 
                "phone": "718-780-3677"
            }, 
            "facility": {
                "address": {
                    "city": "Brooklyn", 
                    "country": "United States", 
                    "state": "New York", 
                    "zip": "11215"
                }, 
                "name": "New Yoyk Methodist Hospital"
            }, 
            "investigator": {
                "last_name": "Jonathan Weinberg, MD", 
                "role": "Sub-Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "3", 
        "official_title": "Phase 3 Study Comparing Transversus Abdominis Plane Block After Caesarian Section Usin Bupivacaine 0.5% vs. Bupivacaine 0.25% vs. Placebo (Normal Saline).", 
        "overall_contact": {
            "email": "adg9003@nyp.org", 
            "last_name": "Adel Guirguis, MD, MS", 
            "phone": "(718) 780-3677"
        }, 
        "overall_official": {
            "affiliation": "New York Methodist Hospital Hospital", 
            "last_name": "Jonathan Weinberg, MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "February 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Transversus Abdominis Plane (TAP) Block for Post Caesarean Pain", 
            "safety_issue": "No", 
            "time_frame": "One Year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01986049"
        }, 
        "responsible_party": {
            "investigator_affiliation": "New York Methodist Hospital", 
            "investigator_full_name": "Joel Yarmush", 
            "investigator_title": "Anesthesiologist", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Pain score measured by Visual Analog Scale (VAS)", 
            "safety_issue": "No", 
            "time_frame": "One year"
        }, 
        "source": "New York Methodist Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "New York Methodist Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}